These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5405 related items for PubMed ID: 23039824

  • 1. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC, Ayala DE, Mojón A, Fernández JR.
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [Abstract] [Full Text] [Related]

  • 2. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC, Ayala DE, Fernández JR, Mojón A.
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC, Ayala DE, Mojón A, Fernández JR.
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [Abstract] [Full Text] [Related]

  • 4. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR.
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [Abstract] [Full Text] [Related]

  • 8. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [Abstract] [Full Text] [Related]

  • 9. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, Piñeiro L, Ríos MT, Otero A, Balan H, Fernández JR.
    Clin Investig Arterioscler; 2013 Mar; 25(2):74-82. PubMed ID: 23849214
    [Abstract] [Full Text] [Related]

  • 10. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
    International Society for Chronobiology, American Association of Medical Chronobiology and Chronotherapeutics, Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk, Spanish Society of Atherosclerosis, Romanian Society of Internal Medicine, Hermida RC, Smolensky MH, Ayala DE, Portaluppi F.
    Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
    Hermida RC, Ayala DE, Mojón A, Fernández JR.
    Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
    [Abstract] [Full Text] [Related]

  • 15. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC, Ayala DE, Mojón A, Fernández JR.
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [Abstract] [Full Text] [Related]

  • 16. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC, Ríos MT, Crespo JJ, Moyá A, Domínguez-Sardiña M, Otero A, Sánchez JJ, Mojón A, Fernández JR, Ayala DE, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [Abstract] [Full Text] [Related]

  • 17. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, de Lis JP, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE, Hermida RC, Mojón A, Fernández JR.
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
    Hermida RC, Ayala DE, Mojón A, Fernández JR.
    Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 271.